Chongqing Lummy Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Lummy Pharmaceutical Co Ltd with three other
companies in this sector in China:
Zhejiang Shapuaisi Pharmaceutical Co Ltd
sales of 921.67 million Chinese Renmimbi [US$136.24 million]
of which 100%
Henan Taloph Pharmaceutical Stock Company Limited
(1.02 billion Chinese Renmimbi [US$150.37 million]
of which 59%
was Medicine Distribute), and
Shanghai Kai Kai Industry Co Ltd
(879.44 million Chinese Renmimbi [US$130.00 million]
of which 91%
During the year ended December of 2015, sales at
Chongqing Lummy Pharmaceutical Co Ltd were 963.85 million Chinese Renmimbi (US$142.48 million).
increase of 5.7%
versus 2014, when the company's sales were 911.69 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Chongqing Lummy Pharmaceutical Co Ltd
(and since 2010, sales have increased a total of 155%).
Sales of Other Operations saw an increase
that was more than double the company's growth rate: sales were up
389.3% in 2015, from
1.77 million Chinese Renmimbi to 8.65 million Chinese Renmimbi.
Chongqing Lummy Pharmaceutical Co Ltd also saw significant increases in sales in
Chemical Manufacturing (up 8.1% to 901.47 million Chinese Renmimbi)
Not all segments of Chongqing Lummy Pharmaceutical Co Ltd experienced an increase in sales in 2015:
sales of Chemical Distribution fell 29.5% to 53.85 million Chinese Renmimbi.